{{Rsnum
|rsid=6751
|Gene=ENAH
|Chromosome=1
|position=225494858
|Orientation=minus
|GMAF=0.3356
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ENAH
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 6.2 | 43.4 | 50.4
| HCB | 8.8 | 30.7 | 60.6
| JPT | 10.6 | 40.7 | 48.7
| YRI | 23.1 | 48.3 | 28.6
| ASW | 14.0 | 50.9 | 35.1
| CHB | 8.8 | 30.7 | 60.6
| CHD | 11.1 | 45.4 | 43.5
| GIH | 36.6 | 46.5 | 16.8
| LWK | 13.8 | 50.5 | 35.8
| MEX | 10.3 | 50.0 | 39.7
| MKK | 8.3 | 45.5 | 46.2
| TSI | 8.8 | 45.1 | 46.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=19641378
|Title=The enabled homolog gene polymorphisms are associated with susceptibility and progression of childhood IgA nephropathy
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}